Norway - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Norway Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes decreased by 0.5% year on year. With €282.56 Per Capita in 2019, the country was number 10 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes. Norway is overtaken by Italy, which was number 9 with €284.66 Per Capita and is followed by Sweden with €272.33 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, +3.2% compared to 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia recorded the best 5 years average growth at +8.8% per year, while Romania witnessed the worst performance at -1.7% per year.

Loading...

Date Euros Per Capita
2019 282.56
2018 280.69
2017 291.03
2016 285.59
2015 299.64
Download all data from 2011 to 2019

How does Norway rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
9 #9
Italy
284.66 2019 +0.3 % +2.7 % View data
10 #10
Norway
282.56 2019 +0.7 % -0.5 % View data
11 #11
Sweden
272.33 2019 +1.1 % +1.7 % View data
Compare all 33 countries

Go Top